Barnett & Company, Inc. Abbott Laboratories Transaction History

Barnett & Company, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$114.02 - $139.04 $9,121 - $11,123	-80 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $9,242 - $11,316	80 New	80 $11,000
Q4 2019 Jan 22, 2020	SELL	$78.51 - $87.4 $39,255 - $43,700	-500 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $40,920 - $44,370	500 New	500 $42,000
Q2 2019 Jul 30, 2019	SELL	$72.88 - $85.0 $7,288 - $8,500	-100 Closed	0 $0

Q1 2019 Apr 26, 2019	BUY	$66.22 - $80.06 $2,450 - $2,962	37 Added 58.73%	100 $8,000
Q4 2018 Feb 15, 2019	SELL	$65.56 - $74.27 $33,435 - $37,877	-510 Reduced 89.01%	63 $5,000
Q3 2018 Nov 02, 2018	BUY	$60.81 - $73.36 $31,013 - $37,413	510 Added 809.52%	573 $42,000
Q2 2018 Aug 03, 2018	BUY	$57.57 - $63.54 $3,626 - $4,003	63 New	63 $4,000
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $33,550 - $35,918	-625 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$48.06 - $53.64 $30,037 - $33,525	625	625 $33,000

3,130

1.29B

8.43M

8.71M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Barnett & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Barnett & Company, Inc. with notifications on news.